1. The document discusses various drug standards including pharmacopoeias, formularies, the United States Pharmacopeia (USP), the British Pharmacopoeia (BP), the British National Formulary (BNF), the Bangladesh National Formulary (BDNF), drug monographs, and drug regulation and control.
2. Pharmacopoeias are authoritative references on drugs that describe identification standards and tests to ensure drug strength, purity and quality. Formularies list drugs and formulas. The USP and BP are the national pharmacopoeias of the United States and United Kingdom, respectively.
3. The BNF provides prescribing information for drugs available through the UK NHS while the BDNF does the
The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011.
The government has notified the DPCO 2013 under the Essential Commodities Act, 1955, which will give power to the NPPA (National Pharmaceutical Pricing Authority (NPPA )to regulate prices of 348 essential drugs along with their specified strengths and dosages under NLEM 2011.
Introduction to Social Pharmacy, Definition, Social Pharmacy as a Discipline, Scope of Social Pharmacy in Improving Public Health, Role of Pharmacist in Public Health, Concept of Health, Dimensions of Health, Determinants of Health, Health Indicators.
This presentation is related to the drug price control order in India. It will give an idea to the readers how the prices have been fixed for the formulations. How the price has been calculated for scheduled formulations.
Social health program; role of world health organization in Indian national p...Dr. Sharad Chand
This topic explains the Social health program; the role of the world health organization in the Indian national program. This is useful for understanding the importance of social health and the role of WHO.
cosmetic and cosmeceutical
Classification of cosmetic and cosmeceutical products
Definition of cosmetics as per Indian and EU regulations, Evolution of cosmeceuticals from cosmetics, cosmetics as quasi and OTC drugs
Cosmetic excipients: Surfactants, rheology modifiers, humectants, emollients, preservatives. Classification and application
Skin: Basic structure and function of skin.
Hair: Basic structure of hair. Hair growth cycle.
Oral Cavity: Common problem associated with teeth and gums
Pharmacy information resources and classification of them
Pharmacy Information Resources
Pharmacy information resources: The medical and pharmaceutical journals, review journals, periodicals, bulletins and books containing specific and particular information and theory about drug molecules are termed 'pharmacy information resources'.
Classification of Pharmacy Resources
There are a lot of sources from where we can get the information of all types of drugs.
Primary source of drug information
Secondary source
Special information
Pharmaceutical database
WHO Bulletin and journals
Drug directory
Physicians' desk reference
Text books of Pharmacy and pharmacology
Handouts of the pharmaceutical manufacturers
Pharmacy Information Resources
Pharmacy information resources: The medical and pharmaceutical journals, review journals, periodicals, bulletins and books containing specific and particular information and theory about drug molecules are termed 'pharmacy information resources'.
Classification of Pharmacy Resources
There are a lot of sources from where we can get the information of all types of drugs.
Primary source of drug information
Secondary source
Special information
Pharmaceutical database
WHO Bulletin and journals
Drug directory
Physicians' desk reference
Text books of Pharmacy and pharmacology
Handouts of the pharmaceutical manufacturers
Introduction to Social Pharmacy, Definition, Social Pharmacy as a Discipline, Scope of Social Pharmacy in Improving Public Health, Role of Pharmacist in Public Health, Concept of Health, Dimensions of Health, Determinants of Health, Health Indicators.
This presentation is related to the drug price control order in India. It will give an idea to the readers how the prices have been fixed for the formulations. How the price has been calculated for scheduled formulations.
Social health program; role of world health organization in Indian national p...Dr. Sharad Chand
This topic explains the Social health program; the role of the world health organization in the Indian national program. This is useful for understanding the importance of social health and the role of WHO.
cosmetic and cosmeceutical
Classification of cosmetic and cosmeceutical products
Definition of cosmetics as per Indian and EU regulations, Evolution of cosmeceuticals from cosmetics, cosmetics as quasi and OTC drugs
Cosmetic excipients: Surfactants, rheology modifiers, humectants, emollients, preservatives. Classification and application
Skin: Basic structure and function of skin.
Hair: Basic structure of hair. Hair growth cycle.
Oral Cavity: Common problem associated with teeth and gums
Pharmacy information resources and classification of them
Pharmacy Information Resources
Pharmacy information resources: The medical and pharmaceutical journals, review journals, periodicals, bulletins and books containing specific and particular information and theory about drug molecules are termed 'pharmacy information resources'.
Classification of Pharmacy Resources
There are a lot of sources from where we can get the information of all types of drugs.
Primary source of drug information
Secondary source
Special information
Pharmaceutical database
WHO Bulletin and journals
Drug directory
Physicians' desk reference
Text books of Pharmacy and pharmacology
Handouts of the pharmaceutical manufacturers
Pharmacy Information Resources
Pharmacy information resources: The medical and pharmaceutical journals, review journals, periodicals, bulletins and books containing specific and particular information and theory about drug molecules are termed 'pharmacy information resources'.
Classification of Pharmacy Resources
There are a lot of sources from where we can get the information of all types of drugs.
Primary source of drug information
Secondary source
Special information
Pharmaceutical database
WHO Bulletin and journals
Drug directory
Physicians' desk reference
Text books of Pharmacy and pharmacology
Handouts of the pharmaceutical manufacturers
Monographs of herbal drugs: General parameters of
monographs of herbal drugs and comparative study in IP, USP,
Ayurvedic Pharmacopoeia, Siddha and Unani Pharmacopoeia,
American herbal pharmacopoeia, British herbal pharmacopoeia,
WHO guidelines in quality assessment of herbal drugs.
www.linkedin.com/in/dr-aboobecker-siddique-p-a-200783a0
General Pharmacology
Introduction to pharmacology
Definition of pharmacology and its subdivisions, Sources of drug info and category of info for each source, Sources of drugs and drug nomenclature.
Pharmaceutics
Routes, Factors determine selection of routes, advantages and disadvantages,of enteral, parenteral inhalational routes, and transdermal routes
Membrane transport mechanism, Bioavailability factors and definition, factors influencing drug distribution pattern, Biotransformation,-Definition, phases, sites, Factors affecting,
Drug elimination-Routes of excretion, factors affecting renal excretion, halflife definition and importance, dose response and steady state concentration
MO drug action, Factors that modify, drug interaction
Safety margin and drug toxicity 1h
TI, Untoward effects-predictable unpredictable and others, Principles of management of drug toxicity
definition
why study pharmacology
subdivision
clinical pharmacology
source of information of drugs
nomenclature of drugs
sources of drugs
pharmacy, the science and art concerned with the preparation and standardization of drugs. Its scope includes the cultivation of plants that are used as drugs, the synthesis of chemical compounds of medicinal value, and the analysis of medicinal agentshttps://labwork360.com/
National Pharmaceutical Pricing Authority (NPPA) & Drug Price Control Order (...Dr. Ambekar Abdul Wahid
Introduction to NPPA, The Drug Regulatory System in India, NPPA Activities and Responsibility's, Function and Organization of NPPA, Introduction to DPCO 2013, Salient features of DPCO 2013, Prices of Bulk Drug, Retail price of Formulations, Pricing of Scheduled Formulations, Various Schedules related to DPCO Act and Amendments.
Sổ tay thuốc thú y - tra liều thuốc thú yLuong Manh
Bác sĩ xem phương pháp tra liều thuốc của EduVET để tận dụng hết công hiệu của cuốn sách này
link cách tra liều thuốc: https://www.facebook.com/groups/448168926123166/
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxDimple Marathe
organization, structure, function of FDA, FR, CFR, FFDCA, Approval process of IND, NDA, ANDA, orphan drug, combination product, changes to approved NDA, ANDA, packaging labelling of pharmaceutical.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Acetabularia Information For Class 9 .docxvaibhavrinwa19
Acetabularia acetabulum is a single-celled green alga that in its vegetative state is morphologically differentiated into a basal rhizoid and an axially elongated stalk, which bears whorls of branching hairs. The single diploid nucleus resides in the rhizoid.
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Overview on Edible Vaccine: Pros & Cons with Mechanism
Drug Standards
1. 1
Noakhali Science and Technology University
Department of Pharmacy
Course Title: Introduction to Pharmacy
Course Code: 1101
Assignment Name: Drug Standards.
Date: 03-04-2018
Submitted to: Fahad Hussain,assistant professor at dep. of pharmacy at NSTU.
Submitted by:
Md. MokabbirHossain Uchsas
Roll: ASH1803004M
2. 2
DRUG STANDARDS
Drug Information: The Pharmacist has the knowledge and expertise to
provide detailed information on medicines to members of the health
professions and the public. Also pharmacists provide an information
service within the company.
Pharmacopeia: A book published usually under the jurisdiction of the
government and containing a list of drugs, their formulas, methods for
making medicinal preparations, requirements and tests for their strength
and purity, and other related information.
Pharmacopoeias and Formularies: Pharmacopoeias are authoritative
treatises on drugs and preparations, their description, formulation,
analytic composition, physical constants, main chemical properties used
in identification, standards for strength, purity, and dosage, chemical tests
for determining identity and purity, etc. They are usually published under
3. 3
governmental jurisdiction. They differ from formularies in that they are
far more complete; formularies simply list drugs or collections of
formulas for the compounding of medicinal preparations. However,
sometimes the terms "pharmacopoeia" and "formulary" are used
interchangeably.
In addition to serving as current reference sources, pharmacopoeias and
formularies provide an historical record of pharmacy practice, drug use,
and drug availability.
NLM collects the national pharmacopoeias of the world insofar as
possible. Other formularies are more selectively acquired, with emphasis
on those likely to be of historical interest. Hospital formularies, which list
all drugs commonly stocked in a hospital pharmacy, generally are not
collected.[1]
USP: The United States Pharmacopeia (USP) is
a pharmacopeia (compendium of drug information) for the United
States published annually by the United States Pharmacopeial
Convention (usually also called the USP), a nonprofit organization that
owns the trademark and copyright. The USP is published in a combined
volume with the National Formulary (a formulary) as the USP-NF. If a
drug ingredient or drug product has an applicable USP quality standard
(in the form of a USP-NF monograph), it must conform in order to use the
designation "USP" or "NF." Drugs subject to USP standards include both
human drugs (prescription, over-the-counter, or otherwise), as well as
animal drugs. USP-NF standards also have a role in U.S. federal law; a
drug or drug ingredient with a name recognized in USP-NF is deemed
adulterated if it does not satisfy compendial standards for strength, quality
or purity. USP also sets standards for dietary supplements, and food
ingredients (as part of the Food Chemicals Codex). USP has no role in
enforcing its standards; enforcement is the responsibility of Food and
4. 4
Drug Administration (FDA) and other government authorities in the U.S.
and elsewhere.[2]
BP : The British Pharmacopoeia (BP)is the national pharmacopoeia of
the United Kingdom. It is an annual published collection of quality
standards for UK medicinal substances. It is used by individuals
and organisations involved in pharmaceutical
research, development, manufacture and testing.
Pharmacopoeial standards are publicly available and legally enforceable
standards of quality for medicinal products and their constituents. The
British Pharmacopoeia is an important statutory component in the control
of medicines which complements and assists the licensing and inspection
processes of the Medicines and Healthcare products Regulatory
Agency (MHRA) of the United Kingdom. Together with the British
National Formulary (BNF), the British Pharmacopoeia defines the UK's
pharmaceutical standards.
Pharmacopoeial standards are compliance requirements; that is, they
provide the means for an independent judgement as to the overall quality
United States Pharmacopeia
Type Nonprofit
Founded 1820
Headquarters Rockville, Maryland, USA
Key people Ronald T. Piervincenzi, Chief Executive Officer
5. 5
of an article, and apply throughout the shelf-life of a product. Inclusion of
a substance in a pharmacopoeia does not indicate that it is either safe or
effective for the treatment of any disease.[3]
BNF: The British National Formulary (BNF) is a United Kingdom
(UK) pharmaceutical reference book that contains a wide spectrum of
information and advice on prescribing and pharmacology, along with
specific facts and details about many medicines available on the
UK National Health Service (NHS). Information within the BNF
includes indication(s), contraindications, side effects, doses, legal
classification, names and prices of available proprietary
and generic formulations, and any other notable points. Though it is a
national formulary, it nevertheless also includes entries for some
medicines which are not available under the NHS, and must be prescribed
and/or purchased privately. A symbol clearly denotes such drugs in their
entry.
It is used by pharmacists and doctors (both general practitioners (GPs)
and specialist practitioners), and by other prescribing healthcare
professionals (such as nurses, pharmacy technicians, paramedics,
and dentists); as a reference for correct dosage, indication, interactions
and side effects of drugs. It is also used as a reassurance by those
administering drugs, for example a nurse on a hospital ward, and even for
patients and others seeking an authoritative source of advice on any aspect
of pharmacotherapy.
The British Pharmacopoeia (BP) specifies quality standards for the
making of drugs listed in the BNF.[4]
British Pharmacopoeia
Headquarters London, United Kingdom
Website www.Pharmacopoeia.com
6. 6
BDNF : Bangladesh National Formulary is an official book of drug and
related items used in Bangladesh. It contains information for prescribing
and dispensing of drugs such as names, indication, side-effects, cautions,
dosages from. BDNF was first published by the directortate of drug
administration, ministry of health and family welfare in 2001. Later
newer version was published in 2006.[5]
Drugmonograph:A publication that specifies for a drug (or class of rela
ted drugs) the kinds and amounts of ingredients it may contain, thecondit
British National Formulary
The standard cover design is easily identified, with each six-monthly edition
distinguished by a different jacket colour. The previous edition (BNF 73
(March 2017)) is shown
Author British Medical Association, and
Royal Pharmaceutical Society
Country United Kingdom
Language British English
Subject Medicine, Pharmacy
Genre Clinical Pharmacy reference
Publisher BMJ Group, and
Pharmaceutical Press
7. 7
ions and limitations for which it may be offered, directions for use, warn
ings, and other information that its labeling mustcontain.
The monograph may contain important information concerning interacti
ons with other drugs. [6]
Drug regulation and control: Reviews the legislative basis of the
regulation of clinical investigation and the approval of new drugs as a
foundation for examination of some current policy issues facing the FDA.
8. 8
Intentions and stipulations of the major legislation passed by Congress,
including the Pure Food and Drug Act of 1906, the Food, Drug, and
Cosmetic Act of 1938, and the New Drug amendments of 1962 are
described, and their basic policies outlined.
The major regulations rooted in that legislation and other guidelines
representing FDA implementation are identified and discussed, including
new drug regulations, guidelines for clinical investigations, and other
aspects of the drug approval process. Proposed legislation affecting new
drug development and clinical investigations, and FDA administrative
proposals affecting revised new drug applications, monitoring of research,
institutional review boards, informed consent, clinical investigations, and
obligations of the sponsor or monitor are examined. Current problems and
proposals involving larger societal issues are also discussed, such as the
therapeutic use of investigational drugs, state drug legislation on
marijuana and laetrile, the alleged drug lag, orphan drugs, and
9. 9
international cooperation in drug development. The paper focuses
throughout on concern about human subject protection and validation of
research data.[7]
10. 10
References:
1. US. National Library of Medicine, national institute of health.
2. NS Pharmacopeial convention (2014-01-18) “Ron Piervinecenzi
Ph.D, Named Next. CEO of USP . PR. Newswire.
3. Medicine Act 1968 Legistation. Gov.uk. Her majestys govt. of the UK.
Retrieved 7november2016.
4. Anon (1957). British Nationl Formulary 1976-8, British Medical
Journal.
5. Bentleys Text book of Pharmaceutics : A. Owen Bentley, and E A
Rawlins.
6. Olivia Pulsinelli (4 March 2014). "BP to create new Houston-
based business to manage onshore U.S. assets".Houston Business
Journal. Retrieved 10 April.
7. "Across Atlantic, Much Ado About Oil Company's Name". The
New York Times.12 June 2010.Archived from the originalon 17 June
2010. Retrieved 17 June 2010.